These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6452816)

  • 21. The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic.
    Warren CA; King BA; Shannon KP; Eykyn SJ; Phillips I
    J Antimicrob Chemother; 1980 Sep; 6(5):607-15. PubMed ID: 6447682
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections.
    Rambo WM; Del Bene VE; Burkey LG; Collins CD; Richmond DK
    Rev Infect Dis; 1982; 4 Suppl():S683-7. PubMed ID: 6218583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxalactam: clinical summary of efficacy and safety.
    Kammer RB
    Rev Infect Dis; 1982; 4 Suppl():S712-9. PubMed ID: 6218589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
    Bartlett JG; Joiner KA; Dezfulian M; Marien GJ
    Rev Infect Dis; 1982; 4 Suppl():S664-9. PubMed ID: 6218580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.
    Trager GM; Panwalker AP; Malow JB; Porembski PE; Ramirez CA; Zar FA
    Chemotherapy; 1981; 27(4):287-95. PubMed ID: 6454542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Moxalactam - a beta-lactam antibiotic in the monotherapy of severe infections in surgery. Clinico-bacteriological study of 35 patients].
    Gonzenbach HR; Sonnabend W
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1169-83. PubMed ID: 6456543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
    Verbist L
    Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moxalactam therapy for bacterial pneumonia.
    Perlino CA
    Rev Infect Dis; 1982; 4 Suppl():S617-22. PubMed ID: 6218574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W; Pegram PS; McCall CE
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic penetration in abdominal infection: a case of tobramycin failure responsive to moxalactam.
    Carson HB; Heller AS; Koch TB; Walczak P; Schentag JJ
    Drug Intell Clin Pharm; 1983 Apr; 17(4):277-9. PubMed ID: 6220879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Moxalactam in complications of abdominal surgery].
    Dupeyron JP; Peter JD; Rigolot JC
    Sem Hop; 1983 Jun; 59(26):1985-9. PubMed ID: 6310792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterococcal infections in patients treated with moxalactam.
    Moellering RC
    Rev Infect Dis; 1982; 4 Suppl():S708-11. PubMed ID: 6218588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current problems in antibiotic treatment in obstetrics and gynecology.
    Ledger WJ
    Rev Infect Dis; 1985; 7 Suppl 4():S679-89. PubMed ID: 3909324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clindamycin in the treatment of obstetric and gynecologic infections: a review.
    Zambrano D
    Clin Ther; 1991; 13(1):58-80. PubMed ID: 2029726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
    Sweet RL; Ohm-Smith M; Landers DV; Robbie MO
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):808-17. PubMed ID: 3895947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
    Stone HH; Kolb L; Geheber CE
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of moxalactam.
    Reed MD; Bertino JS; Aronoff SC; Speck WT; Blumer JL
    Clin Pharm; 1982; 1(2):124-34. PubMed ID: 6224626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experience with moxalactam in the treatment of mixed aerobic-anaerobic surgical infections].
    Gonzenbach HR; Sonnabend W
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):356-62. PubMed ID: 6221243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.